HRP20040278B1 - Gonadotrophins for folliculogenesis - Google Patents

Gonadotrophins for folliculogenesis

Info

Publication number
HRP20040278B1
HRP20040278B1 HR20040278A HRP20040278A HRP20040278B1 HR P20040278 B1 HRP20040278 B1 HR P20040278B1 HR 20040278 A HR20040278 A HR 20040278A HR P20040278 A HRP20040278 A HR P20040278A HR P20040278 B1 HRP20040278 B1 HR P20040278B1
Authority
HR
Croatia
Prior art keywords
folliculogenesis
gonadotrophins
recombinant fsh
preparations
pharmaceutical composition
Prior art date
Application number
HR20040278A
Other languages
English (en)
Croatian (hr)
Inventor
Loumaye Ernest
Emanuele Giartosio Carlo
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23323355&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20040278(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of HRP20040278A2 publication Critical patent/HRP20040278A2/hr
Publication of HRP20040278B1 publication Critical patent/HRP20040278B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HR20040278A 2001-10-22 2004-03-19 Gonadotrophins for folliculogenesis HRP20040278B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33808801P 2001-10-22 2001-10-22
PCT/EP2002/011501 WO2003035686A2 (en) 2001-10-22 2002-10-15 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments

Publications (2)

Publication Number Publication Date
HRP20040278A2 HRP20040278A2 (en) 2005-04-30
HRP20040278B1 true HRP20040278B1 (en) 2008-03-31

Family

ID=23323355

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040278A HRP20040278B1 (en) 2001-10-22 2004-03-19 Gonadotrophins for folliculogenesis

Country Status (24)

Country Link
US (1) US20050085412A1 (xx)
EP (2) EP1621549A3 (xx)
JP (1) JP2005515974A (xx)
KR (1) KR100929971B1 (xx)
CN (1) CN1608078B (xx)
AR (1) AR036926A1 (xx)
AT (1) ATE329930T1 (xx)
AU (1) AU2002340562B2 (xx)
CA (1) CA2464368A1 (xx)
DE (1) DE60212425T2 (xx)
DK (1) DK1438336T3 (xx)
EA (1) EA007030B1 (xx)
ES (1) ES2261740T3 (xx)
HR (1) HRP20040278B1 (xx)
IL (2) IL161235A0 (xx)
ME (1) MEP38608A (xx)
MX (1) MXPA04003352A (xx)
NO (1) NO327966B1 (xx)
PL (1) PL369606A1 (xx)
PT (1) PT1438336E (xx)
RS (1) RS32804A (xx)
UA (1) UA87433C2 (xx)
WO (1) WO2003035686A2 (xx)
ZA (1) ZA200402279B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
BRPI0716997B8 (pt) * 2006-09-10 2021-05-25 Glycotope Gmbh proteína ou composição de moléculas de proteína, métodos para produção e uso da mesma
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
AU2008290217B2 (en) 2007-08-20 2013-09-05 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
WO2010124134A2 (en) * 2009-04-22 2010-10-28 The Regents Of The University Of California In vivo1h magnetic resonance spectroscopy for the diagnosis of testicular function and disease
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
CN102464713A (zh) * 2010-12-21 2012-05-23 上海丽珠制药有限公司 一种***的制备方法
LT3272861T (lt) 2011-01-20 2020-03-25 Protalix Ltd. Alfa-galaktozidazės kompozicijos
JP6087338B2 (ja) 2011-03-31 2017-03-01 フェリング ベスローテン フェンノートシャップ 医薬製剤
WO2012168680A1 (en) * 2011-06-06 2012-12-13 Ferring B.V. Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
SG11201608132UA (en) 2014-04-18 2016-11-29 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
CN117815404A (zh) 2018-05-18 2024-04-05 第一三共株式会社 抗-muc1抗体-药物缀合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
IL130964A0 (en) * 1997-01-16 2001-01-28 Cytel Corp Practical in vitro sialylation of recombinant glycoproteins
PT1102763E (pt) * 1998-08-07 2005-01-31 Applied Research Systems Mimeticos fsh para o tratamento da infertilidade
WO2000024755A1 (en) * 1998-10-28 2000-05-04 Baylor College Of Medicine Ovary-specific genes and proteins
ATE348173T1 (de) * 1999-04-26 2007-01-15 Genentech Inc Zellenzuchtverfahren für glycoproteine
JP2001299362A (ja) * 1999-12-17 2001-10-30 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones

Also Published As

Publication number Publication date
ATE329930T1 (de) 2006-07-15
EA007030B1 (ru) 2006-06-30
DE60212425T2 (de) 2006-11-09
KR100929971B1 (ko) 2009-12-04
KR20040045885A (ko) 2004-06-02
NO327966B1 (no) 2009-11-02
ES2261740T3 (es) 2006-11-16
IL161235A0 (en) 2004-09-27
AR036926A1 (es) 2004-10-13
PL369606A1 (en) 2005-05-02
NO20042061L (no) 2004-07-13
MXPA04003352A (es) 2004-07-08
JP2005515974A (ja) 2005-06-02
EA200400574A1 (ru) 2004-08-26
WO2003035686A2 (en) 2003-05-01
CN1608078A (zh) 2005-04-20
AU2002340562B2 (en) 2008-10-23
EP1621549A2 (en) 2006-02-01
EP1438336B1 (en) 2006-06-14
PT1438336E (pt) 2006-08-31
RS32804A (xx) 2007-02-05
US20050085412A1 (en) 2005-04-21
WO2003035686A3 (en) 2003-10-09
UA87433C2 (xx) 2009-07-27
HRP20040278A2 (en) 2005-04-30
MEP38608A (en) 2011-02-10
DK1438336T3 (da) 2006-10-02
IL161235A (en) 2009-07-20
CN1608078B (zh) 2012-07-25
EP1621549A3 (en) 2006-03-01
ZA200402279B (en) 2005-10-26
EP1438336A2 (en) 2004-07-21
DE60212425D1 (de) 2006-07-27
CA2464368A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HRP20040278B1 (en) Gonadotrophins for folliculogenesis
BR9814743A (pt) Tablete de detergente
RS50101B (sr) Farmaceutski preparati za imunomodulaciju
ATE420893T1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
HK1029124A1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
EP1371664A4 (en) WTI-MODIFIED PEPTIDE
HRP20000181B1 (en) 2-methyl-thieno-benzodiazepine formulation
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
DK1418890T3 (da) Drivmiddel-baserede mikropartikelformuleringer
ES2164098T3 (es) Composiciones farmaceuticas que contienen una proteina bactericida aumentadora de la permeabilidad y un tensioactivo.
DE69734397D1 (de) Tumor-nekrose-faktor ähnliches ligand
BR0205983A (pt) fármacos peptìdicos antiangiogênicos
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
WO2001078682A3 (en) Sustained release drug compositions
AU2002255649A1 (en) Band 3 antigenic peptides, malaria polypeptides and uses thereof
AU2002217781A1 (en) Occlusion devices
DE69938130D1 (de) Neue peptide
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
MXPA05004849A (es) Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola.
TR200200599T2 (tr) İnsan insülini monomerik analogları.
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
DE69726602D1 (en) Hepatitis b inhibitoren
FR2717390B1 (fr) Compositions thérapeutiques à base de peptides capables d'inhiber la libération de pepsine.
BG103873A (en) The use of protein-containing microparticles with adsorbed antibody for the preparation of pharmaceutical composition for intranasal administration

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: LABORATOIRES SERONO SA, CH

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140909

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20161015